-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $60

Benzinga·02/06/2026 15:58:34
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and raises the price target from $55 to $60.